
Deals
SRX Global Agrees to Buy Cell Therapy Developer CERo Therapeutics
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.
Bootstrapped Wealth reported on SRX Global Inc. on October 7, 2026.
October 7, 2026
SRX Global Inc. said on October 7, 2026 that it signed a definitive purchase agreement to acquire CERo Therapeutics, a cell therapy developer, which would become a wholly owned unit of SRX.

Deals
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.